Literature DB >> 14724891

Cost-effectiveness analysis and health care resource allocation: decision rules under variable returns to scale.

Elamin H Elbasha1, Mark L Messonnier.   

Abstract

We argue that health programs are administered in settings that often violate the frequently stated assumption of constant returns to scale in the provision of health services. Three types of returns to scale are identified from the general economic literature: returns to scale with respect to population, effectiveness, and quality. We show that decision rules based on incremental cost-effectiveness ratios or cost-benefit tests are not optimal if returns to scale are not constant. We derive the optimal decision rules under variable returns to scale using optimization techniques, and employ several examples to illustrate the concepts and methods.

Mesh:

Year:  2004        PMID: 14724891     DOI: 10.1002/hec.793

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  13 in total

Review 1.  Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches.

Authors:  Sun-Young Kim; Sue J Goldie
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

2.  The increasingly complex fourth hurdle for pharmaceuticals.

Authors:  Joshua Cohen; Elly Stolk; Maartje Niezen
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

3.  Cost and cost-effectiveness of nationwide school-based helminth control in Uganda: intra-country variation and effects of scaling-up.

Authors:  Simon Brooker; Narcis B Kabatereine; Fiona Fleming; Nancy Devlin
Journal:  Health Policy Plan       Date:  2007-11-17       Impact factor: 3.344

4.  Cost-effectiveness of RAS screening before monoclonal antibodies therapy in metastatic colorectal cancer based on FIRE3 Study.

Authors:  Feng Wen; Yu Yang; Pengfei Zhang; Jian Zhang; Jing Zhou; Ruilei Tang; Hongdou Chen; Hanrui Zheng; Ping Fu; Qiu Li
Journal:  Cancer Biol Ther       Date:  2015-09-29       Impact factor: 4.742

5.  Costs of cervical cancer screening and treatment using visual inspection with acetic acid (VIA) and cryotherapy in Ghana: the importance of scale.

Authors:  Wilm Quentin; Yaw Adu-Sarkodie; Fern Terris-Prestholt; Rosa Legood; Baafuor K Opoku; Philippe Mayaud
Journal:  Trop Med Int Health       Date:  2011-01-09       Impact factor: 2.622

6.  The costs and effects of a nationwide insecticide-treated net programme: the case of Malawi.

Authors:  Warren Stevens; Virginia Wiseman; Juan Ortiz; Desmond Chavasse
Journal:  Malar J       Date:  2005-05-10       Impact factor: 2.979

7.  Costing the distribution of insecticide-treated nets: a review of cost and cost-effectiveness studies to provide guidance on standardization of costing methodology.

Authors:  Jan Kolaczinski; Kara Hanson
Journal:  Malar J       Date:  2006-05-08       Impact factor: 2.979

8.  Modelling the cost-effectiveness of introducing the RTS,S malaria vaccine relative to scaling up other malaria interventions in sub-Saharan Africa.

Authors:  Peter Winskill; Patrick Gt Walker; Jamie T Griffin; Azra C Ghani
Journal:  BMJ Glob Health       Date:  2017-01-24

9.  Cost-effectiveness Analysis of Fluorouracil, Leucovorin, and Irinotecan versus Epirubicin, Cisplatin, and Capecitabine in Patients with Advanced Gastric Adenocarcinoma.

Authors:  Feng Wen; Hanrui Zheng; Yifan Wu; John Wheeler; Xiaoxi Zeng; Ping Fu; Qiu Li
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

10.  Setting priorities for the health care sector in Zimbabwe using cost-effectiveness analysis and estimates of the burden of disease.

Authors:  Kristian Schultz Hansen; Glyn Chapman
Journal:  Cost Eff Resour Alloc       Date:  2008-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.